A5055513055- Cutaneous lymphoproliferative disorders research
- Lymphoma Diagnosis and Treatment
- Palliative Care and End-of-Life Issues
- Blood groups and transfusion
- Innovations in Medical Education
- Advances in Oncology and Radiotherapy
- Cancer Diagnosis and Treatment
- Multiple and Secondary Primary Cancers
- Economic and Financial Impacts of Cancer
- Cancer survivorship and care
- Cancer Immunotherapy and Biomarkers
- Cancer and Skin Lesions
- Nonmelanoma Skin Cancer Studies
- Myasthenia Gravis and Thymoma
- Health Systems, Economic Evaluations, Quality of Life
- Pericarditis and Cardiac Tamponade
- Polyomavirus and related diseases
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Parvovirus B19 Infection Studies
- Chronic Lymphocytic Leukemia Research
- Frailty in Older Adults
- Autoimmune Bullous Skin Diseases
- Clinical practice guidelines implementation
- Renal Transplantation Outcomes and Treatments
Beth Israel Deaconess Medical Center
2014-2024
Harvard University
2009-2024
Brandeis University
2013
Vanderbilt University
2013
Vanderbilt-Ingram Cancer Center
2013
Brigham and Women's Hospital
2010
Dana-Farber Cancer Institute
2010
Moffitt Cancer Center
2006
University of South Florida
2006
Beth Israel Deaconess Hospital
1991
OBJECTIVE: To characterize the dying experience of patients with cancer over last 6 months life. STUDY DESIGN: A retrospective analysis life among colon and non‐small cell lung enrolled in a prospective cohort study from June 1989 to 1991 January 1992 1994. SETTING: Five geographically diverse tertiary care academic medical centers participating Study Understand Patient Prognoses Preferences for Outcomes Risks Treatments (SUPPORT) Project. PARTICIPANTS: All SUPPORT who had either cancer,...
Background: Breast-conserving surgery combined with axillary lymph node dissection and radiotherapy or mastectomy are definitive treatments for women early-stage breast cancer. Little is known about cancer treatment disabilities. Objective: To compare initial between without disabilities to examine the association of differences survival. Design: Retrospective cohort study. Setting: 11 Surveillance, Epidemiology, End Results (SEER) Program tumor registries. Participants: 100 311 who received...
Abstract Introduction/Aims Myasthenia gravis (MG) is a rare, life‐threatening immune‐related adverse effect (irAE) of immune checkpoint inhibitor (ICI) treatment. C5‐complement inhibitors are effective treatments for acetylcholine receptor antibody (AChR ab) positive generalized MG. We describe the use eculizumab/ravulizumab in two patients with MG receiving concomitant pembrolizumab. Methods This was retrospective review medical records. Results Patient 1: An 80‐year‐old male recurrent,...
Roughly 1.1 million cases of cutaneous squamous cell carcinoma (cSCC) occur annually. Although most can be cured with local therapy, up to 8,000 deaths from metastatic cSCC (mcSCC) each year, a number similar that melanoma.1 With no US Food and Drug Administration–approved options available for mcSCC, common approaches include platinum-based chemotherapy off-label cetuximab. These strategies lack durability, overall survival mcSCC is only 10.9 months.2 Clinical responses in have recently...
No abstract available
Objective. To examine stage at diagnosis and survival for disabled Medicare beneficiaries diagnosed with cancer under age 65 compare their experiences those of other persons 65. Data Sources. Surveillance, Epidemiology, End Results (SEER) Program data SEER‐Medicare linked 1988–1999. SEER‐11 includes 11 population‐based tumor registries collecting information on all incident cancers in catchment areas. Tumor registry are enrolled Medicare. Study Design. 307,595 cases non‐small cell lung...
To explore how underlying disability affects treatments and outcomes of disabled women with breast cancer.Surveillance, Epidemiology, End Results program data, linked Medicare files Social Security Administration group.Ninety thousand two hundred forty-three incident cases early-stage cancer under age 65; adjusted relative risks hazards ratios examined survival, respectively, for in four groups compared nondisabled women.Demographic characteristics, treatments, survival varied among groups....
Abstract Hypertrophic lichen planus ( HLP ) is a T‐cell‐mediated process typically presenting with hypertrophic or verrucous plaques on the lower limbs. We report case of 24‐year‐old woman history since age 3 years rapid malignant transformation one lesion into large squamous cell carcinoma SCC ). Subsequent examination revealed progressive, widespread metastatic involvement, and patient ultimately died from her disease. associated rare, review literature revealing fewer than 50 cases. This...